What's new? Log in Free sign up

Filing search / Standard BioTools Inc. / "Access"

Search information

Standard BioTools Inc.

Companies

"Access"

Keywords

SEC filings

Source

Export list of results

Export a CSV file of filings or unique companies (up to first 5,000 results).

Download list of filings Download list of companies

285 results

Newest first Best match first

LAB Standard BioTools Inc.

Quarterly report

of the Co-Branded Kits is probable due to the launch of an early-access program, and adjusted the transaction price to include $127.9 million … in the proteomics industry —11,000 protein measurements simultaneously from sample volumes as low as 55 µl—giving researchers access to half of the human

6 Nov 24

5:17pm

LAB Standard BioTools Inc.

Standard BioTools Reports Third Quarter 2024 Financial Results

-over-year. Consumables revenue grew on the strength of assay kits sales to SomaScan authorized sites and the Illumina early access program. Instruments

LAB Standard BioTools Inc.

Standard BioTools 1 Unleashing Tools to Accelerate Breakthroughs in Human Health INVESTOR PRESENTATION September 2024

SomaScan Assay Kits business up over 2023 from continued expansion in authorized sites and related pull-through Illumina early access program

LAB Standard BioTools Inc.

Departure of Directors or Certain Officers

that the claimant will be provided, upon request and free of charge, reasonable access to, and copies of, all documents and other information relevant

LAB Standard BioTools Inc.

Quarterly report

determined that commercialization of the Co-Branded Kits is probable due to the launch of an early-access program, and adjusted the transaction price … revenue and operating cash flow and our ability to access additional funding through either equity offerings, issuances of debt instruments or both. Our

6 Aug 24

4:30pm

boacrai48j0bgqm 7s34

Shelf registration

18 Jun 24

5:43pm

Additional proxy soliciting materials

xq2ckwt6dew4nze9hwnn

Conflict minerals disclosure

j8fmbd8r lceoiqgv

Proxy in contested solicitation

Preliminary revised proxy

Preliminary proxy with contested solicitation

Quarterly report

9 May 24

4:53pm

vvkbkmznllssuq6

Standard BioTools Reports First Quarter 2024 Financial Results

Annual report (amended)

26 Apr 24

5:01pm

cein6 sga8j3zh423e

1 Mar 24

4:09pm

cte4zx3 q4qswhvc

Shelf registration

19 Jan 24

5:07pm

Shelf registration

19 Jan 24

5:05pm

Financial Statements and Exhibits

Financial Statements and Exhibits

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2023 Revenue

Prev
1
2
3
4
5
...
Next

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.